Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Auxilium Pharmaceuticals, Inc.
Auxilium Pharmaceuticals reports revenues of $14.9M
June 2nd, 2006
Auxilium Pharmaceuticals, Inc., (AUXL) announced financial results for the quarter ended March 31, 2006. For the first quarter of 2006, Auxilium reported net revenues of $14.9 million compared to net revenues of $8.8 million in the first quarter of 2005. "Testim delivered another quarter of record performance with solid growth in sales, prescriptions and market share, marking the 12th consecutive quarter of all-time high net revenues for Auxilium," said Gerri Henwood, CEO. "Testim continues to be an important source of support for the company and the late-stage clinical development programs that we look forward to advancing into pivotal trials later...
Source: Medicine & Law Weekly (2006-06-02)
|
